Cargando…
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
BACKGROUND: Taking advantage of nanobodies (Nbs) in immunotherapy, we investigated the cytotoxicity of Nb-based chimeric antigen receptor T cells (Nb CAR-T) against lymphoma cells. METHODS: CD19 Nb CAR-T, CD20 Nb CAR-T, and Bispecific Nb CAR-T cells were generated by panning anti-human CD19- and CD2...
Autores principales: | Wang, Hongxia, Wang, Liyan, Li, Yanning, Li, Guangqi, Zhang, Xiaochun, Jiang, Dan, Zhang, Yanting, Liu, Liyuan, Chu, Yuankui, Xu, Guangxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386010/ https://www.ncbi.nlm.nih.gov/pubmed/34429118 http://dx.doi.org/10.1186/s12935-021-02151-z |
Ejemplares similares
-
Screening and identification of an anti-PD-1 nanobody with antitumor activity
por: Zhang, Yanting, et al.
Publicado: (2023) -
Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory
por: Wang, Hongxia, et al.
Publicado: (2022) -
The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021) -
Nanobody-based CAR-T cells for cancer immunotherapy
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2022) -
Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics
por: Jiang, Dan, et al.
Publicado: (2020)